¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"target cell anemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® target tissue ÇÑ±Û Ç¥ÀûÁ¶Á÷
¼³¸í   
  È£¸£¸ó¿¡ ´ëÇÏ¿© Ç¥ÀûÀÌ µÇ´Â ¼¼Æ÷¶ó´Â Àǹ̷μ­ ±× È£¸£¸ó¿¡ ´ëÇÑ ¼ö¿ëü¸¦ °¡Áö°í Àִ ¼¼Æ÷. ¿¹¸¦ µé¾î Àν¶¸°Àº Àν¶¸° ¼ö¿ëü¸¦ °¡Áø ¼¼Æ÷¸¦ Ç¥Àû¼¼Æ÷·Î ÇÏ¿© ÀÌ ¼¼Æ÷¿¡¸¸ ÀÛ¿ëÇÑ´Ù.
¿µ¹® anemia ÇÑ±Û ºóÇ÷
¼³¸í   
  Ç÷¾×ÀÌ ¼øÈ¯Çϴ ¸ñÀû Áß¿¡¼­ °¡Àå Áß¿äÇÑ °ÍÀº ¿©·¯ °¡Áö ¿µ¾ç¼Ò¸¦ ¸»ÃÊÀÇ Àå±â·Î º¸±ÞÇÏ°í ¸»ÃÊÀÇ Àå±â¿¡¼­ ³ª¿À´Â ¿©·¯ ³ëÆó¹°À» ÄáÆÏÀ̳ª Æó·Î º¸³» ¹è¼³¹°À» Ã³¸®Çϴ µ¥ ÀÖ´Ù. ±× Áß¿¡¼­ »ê¼ÒÀÇ ¿î¹ÝÀº °¡Àå Áß¿äÇѵ¥ ¹Ù·Î ÀÌ »ê¼ÒÀÇ ¿î¹ÝÀ» ´ã´çÇϴ °ÍÀÌ ÀûÇ÷±¸ÀÌ´Ù. ÀûÇ÷±¸¿¡´Â Ç÷»ö¼Ò¶ó´Â ¹°ÁúÀÌ ÀÖ¾î À̰ÍÀÌ »ê¼Ò¿Í °áÇÕÇÏ¿© »ê¼Ò¸¦ ¸»ÃÊÀÇ Àå±â·Î ¿î¹ÝÇÒ ¼ö°¡ ÀÖ´Ù.
  
  ºóÇ÷À̶õ ´ÜÀ§ºÎÇÇÀÇ Ç÷¾×¼Ó¿¡ ÀûÇ÷±¸ÀÇ ¾çÀÌ ÀûÀº °æ¿ì¸¦ ¸»ÇÑ´Ù. ÀûÇ÷±¸ÀÇ ¾çÀ» ³ªÅ¸³»´Â °ÍÀ¸·Î´Â 3°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀûÇ÷±¸ÀÇ ¼ýÀÚ¸¦ Á÷Á¢ Ç¥ÇöÇϴ ¹æ¹ý°ú, Ç÷»ö¼ÒÀÇ ¾çÀ» Á¤·®ÇÏ¿© ±× ¾çÀ» Ç¥½ÃÇϴ ¹æ¹ý°ú, Ç÷¾×¼Ó¿¡¼­ ÀûÇ÷±¸°¡ Â÷ÁöÇϴ ¾ç(ÀûÇ÷±¸µîÀûÀ²)À» ³ªÅ¸³»´Â ¹æ¹ýÀÌ ±×°ÍÀÌ´Ù. ´ë°³ ºóÇ÷À̶ó ÇÔÀº ³²¼º¿¡¼­ Ç÷»ö¼Ò < 14g/dl, Ç÷»ö¼Ò < 42%, ÀûÇ÷±¸ÀÇ ¼ö < 4,000,000/mm3ÀÏ °æ¿ìÀ̰í, ¿©¼º¿¡¼± Ç÷»ö¼Ò < 12g/dl, Ç÷»ö¼Ò < 36%, ÀûÇ÷±¸ÀÇ ¼ö < 3,300,000/mm3ÀÏ °æ¿ì¸¦ ÁöĪÇÑ´Ù.
¿µ¹® pernicious anemia ÇÑ±Û ¾Ç¼ººóÇ÷
¼³¸í   
  ¾Ç¼º(»ý¸íÀ» À§ÇùÇϸç, Ä¡·á¿¡ ÀúÇ×Çϴ °æ¿ì¿¡ ´ë°³ ¾Ç¼ºÀ̶ó ºÎ¸§. ¿¹¸¦ µé¾î ÁøÇàµÈ ¾ÏÀÇ °æ¿ì)À̶ó À̸§ºÙ¾î ÀÖÁö¸¸, ½ÇÁ¦ÀûÀ¸·Î´Â ¾Ç¼ºÀÌ ¾Æ´Ï´Ù. ºóÇ÷ÀÇ ÀÏÁ¾ÀÌ´Ù. Á¤»óÀûÀ¸·Î ÀûÇ÷±¸´Â ¹ß´Þ°ú ¼º¼÷°úÁ¤¿¡¼­ ºñŸ¹Î B12°¡ ÇʼöÀûÀÌ´Ù. ÀÌ ºñŸ¹Î B12ÀÇ Ç÷Áß³óµµ°¨¼Ò¿¡ ÀÇÇØ ÀûÇ÷±¸»ý¼º¿¡ ÁöÀåÀ» °¡Á®¿À°Ô µÇ°í, Ç÷¾×³»¿¡ Æ¯Â¡ÀûÀΠ°Å´ëÀû¸ð±¸(megaloblast)ÀÇ Çü¼ºÀÌ ³ªÅ¸³ª´Â Áúº´À» ¸»ÇÑ´Ù.
¿µ¹® hemolytic anemia ÇÑ±Û ¿ëÇ÷ºóÇ÷
¼³¸í   
  ¿ëÇ÷ºóÇ÷À̶õ ÀûÇ÷±¸ÀÇ °úµµÇÑ ÆÄ±«¿¡ ÀÇÇÑ ºóÇ÷ÀÌ´Ù. ¿ø·¡ 120ÀÏ Á¤µµÀÇ ¼ö¸íÀ» °¡Áö´Â ÀûÇ÷±¸ÀÇ ¼ö¸íÀ̠ª¾ÆÁö´Â °ÍÀÌ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ Àִµ¥ ´ëÇ¥ÀûÀΠ¿øÀÎÀ¸·Î´Â ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ »ý±â´Â °Í(¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ)°ú ÀûÇ÷±¸ÀÚüÀÇ ÀÌ»ó(À¯Àü¼ºµÕ±ÙÀûÇ÷±¸Áõ), ±×¸®°í ´Ù¸¥ Áúº´¿¡ ÀÇÇØ¼­ 2Â÷ÀûÀ¸·Î »ý±â´Â °ÍÀÌ ÀÖ´Ù.
¿µ¹® aplastic anemia ÇÑ±Û Àç»ýºÒ·®ºóÇ÷
¼³¸í   
  Àç»ýºÒ·®¼º ºóÇ÷À̶õ °ñ¼öÀÇ ÀÌ»óÀ¸·Î »ý±â´Â ºóÇ÷ÀÌ´Ù. °ñ¼ö¶õ »À¼Ó¿¡ Á¸ÀçÇϴ °ÍÀ¸·Î Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷µé°ú ¹Ì¼º¼÷ÇÑ Ç÷±¸µé·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. À̰͵éÀÌ ¿©·¯ °¡Áö ¿øÀο¡ ÀÇÇØ¼­ ÆÄ±«µÇ¾úÀ» ¶§ »ý±â´Â ºóÇ÷À» Àç»ýºÒ·®ºóÇ÷À̶ó°í ÇÑ´Ù. ±×·¯¹Ç·Î ÀûÇ÷±¸¸¸ÀÇ °¨¼Ò°¡ ¾Æ´Ï¶ó ¸ðµç Ç÷±¸ ¼¼Æ÷ÀÇ °¨¼Ò¸¦ º¼ ¼ö ÀÖ´Ù. Ä¡·á·Î´Â Ç÷±¸ »ý¼ºÀ» ÀÚ±ØÇϴ ȣ¸£¸óÀ» Åõ¿©Çϴ °ÍÀÌ ÀÖÁö¸¸ À̰ÍÀ¸·Î´Â ÆÄ±«µÈ Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷ÀÇ Àç»ýÀÌ ÀϾÁö ¸øÇϹǷΠ¿ÏÀüÇÑ Ä¡·á¶ó°í´Â º¼ ¼ö°¡ ¾ø´Ù. ¿ÏÀüÇÑ Ä¡·á·Î´Â ³²ÀÇ °ñ¼ö¸¦ Ã¤ÃëÇØ¼­ À̰Ϳ¡¼­ºÎÅÍ Ç÷±¸¸¦ »ý¼ºÇϴ ¼¼Æ÷¸¦ ºÐ¸®, È¯ÀÚ¿¡°Ô À̽ÄÇϴ °ñ¼öÀ̽ÄÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell anemia
    Ç¥Àû¼¼Æ÷ºóÇ÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • source-target distance
    ¿øÃµÇ¥Àû»çÀ̰Ÿ®, ¿øÃµÇ¥Àû°£°Å¸®
  • target
    1. Ç¥Àû 2. Ç¥Àû¼¼Æ÷
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • target gland
    Ç¥Àû»ù, Ç¥Àû¼±
  • target lesion
    Ç¥Àûº´ÅÍ
  • target organ
    Ç¥ÀûÀå±â
  • target population
    Ç¥ÀûÁý´Ü
  • target sign
    Ç¥Àû¡ÈÄ
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
  • crescent cell anemia
    Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷, °â»óÀûÇ÷±¸ºóÇ÷
  • aplastic anemia
    Àç»ýºÒ·®ºóÇ÷, ¹«Çü¼ººóÇ÷
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • target organ
    Ç¥ÀûÀå±â
  • anemia of chronic disease
    ¸¸¼ºº´ºóÇ÷
  • anemia
    ºóÇ÷
  • aplastic anemia
    Àç»ýºÒ·®ºóÇ÷, ¹«Çü¼ººóÇ÷
  • fetal anemia
    žƺóÇ÷
  • hemolytic anemia
    ¿ëÇ÷ºóÇ÷
  • iron deficiency anemia
    ö°áÇ̺óÇ÷
  • macrocytic anemia
    Å«ÀûÇ÷±¸ºóÇ÷
  • megaloblastic anemia
    °Å´ëÀûÇ÷¸ð±¸ºóÇ÷
  • pernicious anemia
    ¾Ç¼ººóÇ÷
  • cell
    ¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸ºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷
  • crescent cell anemia
    Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia meniscocytosis
    ³´ÀûÇ÷±¸ºóÇ÷
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • clinical target volume
    ÀÓ»óÇ¥ÀûüÀû
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • source-target distance
    ¼±¿øÇ¥Àû°£°Å¸®
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
  • target gland
    Ç¥Àû»ù
  • target lesion
    Ç¥Àûº´ÅÍ
  • target organ
    Ç¥ÀûÀå±â
  • planning target volume
    °èȹǥÀûºÎÇÇ
  • target population
    Ç¥ÀûÁý´Ü
  • target skin distance radiation
    Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • fusional target
    À¶ÇÕÇ¥Áö
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • radiation,target theory of
    ¡­ÀÇ Ç¥ÀûÀÌ·Ð(¡­øöîÜìµÖå)
  • globe cell anemia
    ±¸»óÀûÇ÷±¸¼º ºóÇ÷(ϹßÒîåúìϹàõÞ¸
  • globe cell anemia
    ±¸»óÀûÇ÷±¸¼º ºóÇ÷(Ë´Ë×ËøÌ´Ë´ËÛË×Ì´).
  • pure red cell anemia
    (ÁøÁ¤)ÀûÇ÷±¸°è ºóÇ÷(òØïáîåúìϹͧ޸úì).
  • pure red cell anemia
    (ÁøÁ¤)ÀûÇ÷±¸°è ºóÇ÷((òØïá)îåúìϹͧ Þ¸úì)
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • quiescent cell, Q cell
    Á¤Áö¼¼Æ÷
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷.
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷
  • Cooleys anemia
    Äí¿ï¸®ºóÇ÷.
  • Diamond-Blackfan anemia
    ´ÙÀ̾Ƹóµå-ºí·¢ÆÇ ºóÇ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
  • target cell anemia
    Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell, target
    Ç¥Àû¼¼Æ÷
  • codocyte= target cell
    Ç¥Àû¼¼Æ÷
  • leptocytes = target cell
    Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
  • target cell
    Ç¥Àû¼¼Æ÷
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • clinical target volume, CTV
    ÀÓ»óÇ¥ÀûüÀû
  • fusional target
    À¶ÇÕÇ¥Áö
  • maximum target dose
    ÃÖ°íÇ¥Àû¼±·®
  • mean target dose
    Æò±ÕÇ¥Àû¼±·®
  • median target absorbed dose
    Áß¾ÓÇ¥ÀûÈí¼ö¼±·®
  • median target dose
    Áß¾ÓÇ¥Àû¼±·®
  • minimum target dose
    ÃÖ¼ÒÇ¥Àû¼±·®
  • modal target dose
    ÃÖºóÇ¥Àû¼±·®
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • radiation,target theory of
    ¡­ÀÇ Ç¥ÀûÀÌ·Ð(¡­øöîÜìµÖå)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immune cause (Hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
    [¿¾ ¿ë¾î] ¸é¿ª¼º¿øÀÎ
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷(Á¦1Çü»ç±¸¼¼Æ÷)
  • Clear cell [Epinephrine cell]
    ¹àÀº¼¼Æ÷ [¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¸í¼¼Æ÷(¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Sustentacular cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
  • Secretory epithelial cell [Glandular cell]
    ºÐºñ»óÇǼ¼Æ÷ [»ù¼¼Æ÷]
    [¿¾ ¿ë¾î] ºÐºñ»óÇǼ¼Æ÷
  • Interstitial cell [Dark cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Interstitial cell [Leydig`s cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Bronchiolar cell [Clara cell]
    ¼¼±â°üÁö¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐºñ¼¼Æ÷
  • Parafollicular cell [Calcitonin cell]
    ¼ÒÆ÷°ç¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÆ÷¹æ¼¼Æ÷
  • Neurolemmal cell [Schwann`s cell]
    ½Å°æÁý¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æÃʼ¼Æ÷
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
  • Dark cell [Norepinephrine cell]
    ¾îµÎ¿î¼¼Æ÷ [³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾Ï¼¼Æ÷(³ë¸£¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Supporting cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bothriocephalus anemia
    ¿­µÎÁ¶ÃæºóÇ÷
  • hookworm anemia
    ±¸ÃæºóÇ÷
  • excretory cell
    ¹è¼³¼¼Æ÷
  • flame cell
    ºÒ²É¼¼Æ÷
  • G cell G
    ¼¼Æ÷
  • germ cell
    ¹è¼¼Æ÷
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • nurse cell
    º¸¸ð¼¼Æ÷
  • renette cell
    ¹è¼³¼¼Æ÷
  • tegumental cell
    Ç¥ÇǼ¼Æ÷
  • vitelline cell
    ³­È²¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target cell
    Ç¥Àû¼¼Æ÷ (øöîÜá¬øà)
  • sickle cell anemia
    ³´¼¼Æ÷(á¬øà)ºóÇ÷(Þ¸úì)
  • target molecular weight
    Ç¥ÀûºÐÀÚ·® (øöîÜÝÂí­Õá)
  • target organ
    Ç¥Àû±â°ü (øöîÜÐïί)
  • target sequence
    Ç¥Àû¼­¿­ (øöîÜßíÖª)
  • target theory
    Ç¥ÀûÀÌ·Ð (øöîÜ×âÖå)
  • acquired hemolytic anemia
    "ȹµæ¿ëÇ÷¼ººóÇ÷ (üòÔðéÁúìàõÞ¸úì), ÈÄõ¿ëÇ÷¼ººóÇ÷ (ý­ô¸éÁúìàõÞ¸úì)"
  • anemia
    ºóÇ÷(Þ¸úì)
  • antipernicious anemia factor
    Ç×(ù÷)¾Ç¼ººóÇ÷(äÂàõÞ¸úì) ÀÎÀÚ(ì×í­)
  • Cooley's anemia
    "Ä𸮠ºóÇ÷(Þ¸úì), = thalassemia"
  • Fanconi's anemia
    ÆÇÄÚ´Ï ºóÇ÷(Þ¸úì)
  • hemolytic anemia
    ¿ëÇ÷ ºóÇ÷(éÁúìÞ¸úì)
  • hypochromic anemia
    Àú»ö¼Ò¼ººóÇ÷(î¸ßäáÈàõÞ¸úì)
  • pernicious anemia
    ¾Ç¼º ºóÇ÷(äÂàõÞ¸úì)
  • absorption cell
    Èí¼ö¼Ò°ü (ýåâ¥á³Î·)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
  • target
    Ç¥Àû, °ú³á
  • target configuration
    °ú³á¸ð¾ç, Ç¥Àû¸ð¾ç
  • target organ
    Ç¥Àû±â°ü
  • target pattern
    °ú³á¾ç»ó
  • target sign
    °ú³á¡ÈÄ
  • anemia
    ºóÇ÷
  • aplastic anemia
    ¹«Çü¼º¼ººóÇ÷, Àç»ýºÒ·®¼ººóÇ÷
  • deficiency anemia
    °áÇ̼ººóÇ÷
  • hemolytic anemia
    ¿ëÇ÷¼ººóÇ÷
  • hypochromic anemia
    Ç÷»ö¼Ò°¨¼Ò¼º ºóÇ÷, Àú»ö¼Ò¼ººóÇ÷
  • iron deficiency anemia
    ö°áÇ̼ººóÇ÷
  • secondary anemia
    ¼Ó¹ß¼ººóÇ÷
  • acinar cell
    Æ÷»ó¼¼Æ÷
  • air cell
    ÇԱ⵿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
MC mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med...
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
SCA self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima...
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
E/T effector to target cell
TC target cell
AISA Acquired Idiopathic Sideroblastic Anemia
ACD Anemia of chronic disorders
AA Aplastic Anemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • target cell
    Àû»ó ÀûÇ÷±¸, Ç¥Àû ÀûÇ÷±¸
    1. º´ÀûÀ¸·Î ¾ãÀº ÀûÇ÷±¸·Î¼­ ¿°»öÇÏ¸é ¾Ï»öÀÇ Á߽ɰú ±× µÑ·¹ÀÇ Çì¸ð±Û·Îºó °í¸®°¡, Çì¸ð±Û·ÎºóÀ» º°·Î ÇÔÀ¯ÇÏÁö ¾ÊÀº ´ã»ö ºñ¿°»ö ºÎºÐÀÇ È¯°ú ±¸º°µÇ¾î ³ªÅ¸³­´Ù. À̰ÍÀº ¼±Ãµ¼º, ÈÄõ¼º ºóÇ÷°ú °£Àå Áúȯ, ƯÈ÷ Æó¼â¼º Ȳ´Þ µîÀÇ Áúȯ¿¡¼­ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù. 2. È£¸£¸ó ȤÀº ¾à¹°°ú °°Àº Ư¼ö ¹°Áú¿¡ ÀÇÇÏ¿© ¼±ÅÃÀûÀ¸·Î ¿µÇâÀ» ¹Þ´Â ¼¼Æ÷. 3. NK ¼¼Æ÷, ¼¼Æ÷ µ¶¼º T ¼¼Æ÷, K ¼¼Æ÷ ¶Ç´Â ƯÀÌ Ç×ü¿¡ °ø°Ý ¸ñÇ¥°¡ µÇ´Â Ç׿ø º¸À¯ ¼¼Æ÷.
  • mean target dose
    Æò±Õ Ç¥Àû ¼±·®
  • projection target
    Åõ»ç Ç¥Àû
  • target
    ´ë»ó, Ç¥Àû, ¸ñÇ¥¹°
    1. ¾î¶² °ÍÀÌ ÇâÇÏ´Â ¸ñÀû¹° ¶Ç´Â Àå¼Ò. ¿¹ÄÁ´ë ¿¢½º¼± °ü¿¡ À־, ÀüÀÚ°¡ Ãæµ¹µÇ¾î ¿¢½º¼±À» ¹ßÇÏ´Â ±Ý¼Ó ¶Ç´Â ÆÇ°ú °°Àº °Í. 2. ¾î¶² Ư¼ö ¹°Áú
  • target lesion
    ¸ñÇ¥ º´¼Ò, Ç¥Àû º´¼Ò
  • target material
    Ÿ°Ù ¹°Áú
  • target organ
    Ç¥Àû ±â°ü
    È£¸£¸óÀÌ ±× Ư¼º¿¡ µû¶ó ¾î¶² ÀÏÁ¤ÇÑ Á¶Á÷À̳ª ±â°ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¶§ À̵é Á¶Á÷À̳ª ±â°üÀ» Ç¥Àû ±â°üÀ̶ó ÇÑ´Ù.
  • target sign
    °ú³á ¡ÈÄ
  • target type
    ¸ñÇ¥¹° ÇüÅÂ
  • target-object distance
    Ç¥Àû-ÇÇ»çü °Å¸®
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • acute cerebral anemia
    ±Þ¼º ³ú ºóÇ÷
  • aplastic anemia
    Àç»ý ºÒ·®¼º ºóÇ÷, ¹«Çü¼º ºóÇ÷, ¹«Çü¼º¼º ºóÇ÷, Àç»ýºÒ´É ºóÇ÷
    Ư¼öÇÑ ºóÇ÷ Ä¡·á¿¡ ÀϹÝÀûÀ¸·Î ¹ÝÀÀÀÌ ¾ø´Â ºóÇ÷ÀÇ ÇÑ Á¾·ù. Á¾Á¾ °ú¸³±¸ ºÎÁ·À̳ª Ç÷¼ÒÆÇ ºÎÁ·ÀÌ µ¿¹ÝµÇ´Âµ¥ À̰ÍÀº °ñ¼ö°¡ ¹«¼¼Æ÷À̰ųª Çü¼º ´É·ÂÀÇ ÀúÇϰ¡ ¾Æ´Ï¶ó ¸»ÃÊ Ç÷¾× ¼ººÐÀ» ÀûÀýÈ÷ »ý»êÇÏÁö ¸øÇϱ⠶§¹®ÀÌ´Ù. ÀÌ ´Ü¾î´Â ½ÇÁ¦ ¸î¸îÀÇ ÀÓ»óÀû ÁõÈıºÀ» Æ÷ÇÔÇÏ´Â ¿ë¾î´Ù.
  • chronic hypochromic anemia
    ¸¸¼º Àú»ö¼Ò¼º ºóÇ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anemia <haematology> Too few red blood cells in the bloodstream, resulting in insufficient oxygen to tissues and organs.
Origin: Gr. Haima = blood
(16 Dec 1997)
target cell An erythrocyte in target cell anaemia, with a dark centre surrounded by a light band that again is encircled by a darker ring; it thus resembles a shooting target; such cell's also appear after splenectomy.
A cell lysed by cytotoxic T lymphocytes, as in graft rejection.
Synonym: Mexican hat cell.
(05 Mar 2000)
target cell anaemia Any anaemia with a conspicuous number of target cells in the peripheral blood; characteristic of the thalassaemias and also found in several haemoglobinopathies.
(05 Mar 2000)
GI-tract target lesion <radiology> Metastatic melanoma, primary neoplasm, spindle cell tumour (benign or malignant), lymphoma, carcinoid, carcinoma, metastasis, breast carcinoma, lung carcinoma, renal carcinoma, Kaposi's sarcoma, eosinophilic granuloma, ectopic pancreas
(12 Dec 1998)
molybdenum target tube An X-ray tube with an anode surface made of molybdenum instead of tungsten, used in mammography.
(05 Mar 2000)
target 1. An object fixed as goal or point of examination.
2. In the ophthalmometer, the mire.
Synonym: target organ.
4. Anode of an X-ray tube.
See: X-ray.
Origin: It. Targhetta, a small shield
(05 Mar 2000)
target behaviour Operant in behaviour modification therapy, the prescribed behaviour.
(05 Mar 2000)
target gland The effector that functions when stimulated by the internal secretion of another gland or by some other stimulus.
(05 Mar 2000)
target lesions of liver/spleen <radiology> Lymphosarcoma (including Kaposi sarcoma), melanoma
(12 Dec 1998)
target organ A tissue or organ upon which a hormone exerts its action; generally, a tissue or organ with appropriate receptors for a hormone.
Synonym: target.
(05 Mar 2000)
target patient In group therapy, the patient being analyzed in turn by another member patient.
(05 Mar 2000)
target plasma <radiobiology> Plasma used to trap a neutral atom beam. A background plasma of sufficiently high density and temperature can ionize neutral atoms more effectively than the Lorentz process (where v cross B creates effective electric field).
(09 Oct 1997)
target regulation <physiology> General term for an interaction between neurons and their targets by which target derived signals influence the differentiation of the innervating neurons.
(18 Nov 1997)
target response In conditioning, any behaviour or specific response chosen by the experimenter; its frequency is intended to increase or decrease by the judicious pairing with it of a reinforcer when it occurs.
Synonym: target behaviour, target response.
(05 Mar 2000)
T-cell-rich, B-cell lymphoma <tumour> A B-cell lymphoma in which more than 90% of the cells are of T-cell origin, masking the large cells that form the neoplastic B-cell component.
See: adult T-cell lymphoma.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • target
    Ç¥Àû
  • target
    °ú³á;¸ñÇ¥;¸ñÇ¥¾×;hit a ~ °ú³á¿¡ ¸ÂÈ÷´Ù;¸ñÇ¥¾×¿¡ ´ÞÇÏ´Ù
  • target practice
    »ç°Ý¿¬½À
  • anemia
    ¾Ç¼ººóÇ÷
  • Fanconi's anemia
    ÆÇÄڴϺóÇ÷
  • anemia
    ºóÇ÷Áõ
  • cerebral anemia
    ³úºóÇ÷
  • pernicious anemia
    ¾Ç¼º ºóÇ÷
  • cell
    ¼¼Æ÷
  • HeLa cell
    Èú·¯ ¼¼Æ÷(¿¬±¸¿ëÀ¸·Î ¹è¾çµÇ°í ÀÖ´Â ¾Ï¼¼Æ÷ÀÇ ÀÏÁ¾)
  • blood cell
    Ç÷±¸
  • brain cell
    ³ú½Å°æ¼¼Æ÷
  • cadmium cell
    Ä«µå¹Å ÀüÁö
  • cell
    ÀÛÀº¹æ;¾ÏÀÚ(¼öµµ¿ø ºÎ¼ÓÀÇ);»ç½Ç;¿ÀµÎ¸·Áý;¹«´ý;(±³µµ¼ÒÀÇ)µ¶¹æ;(¹úÁýÀÇ)±¸¸Û;²É°¡·çÁÖ¸Ó´Ï;ÀüÁö;¼¼Æ÷;(Á¶Á÷³»ÀÇ)ÀÛÀº °øµ¿;¼¼Æ÷(°ø»ê´ç µîÀÇ);°¡½ºÅë(±â±¸ÀÇ);ºñÆ®ÀÇ ±â¾ï¼ÒÀÚ;µ¶¹æ»ìÀÌÇÏ´Ù;ÀÛÀº ¹æ¿¡ Ʋ¾î¹ÚÈ÷´Ù
  • cell body
    ¼¼Æ÷ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á